MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
OCGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ocugen (OCGN) Ownership - Who owns Ocugen?

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
11 Great Valley Parkway
Phone
+1 484 328-4701
Employees
116
Web
https://www.ocugen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
397.76M
P/E Ratio
N/A
Total Cash
31.86M
Projected Growth
N/A
Total Debt
33.3M
Revenue
4.47M
Risk (Beta)
2.25
Dividend Yield
N/A
Total Cash/Share
0.09
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Trend Trader: Popular Stocks, 60 min, (TA&FA)Trend Trader: Popular Stocks, 60 min, (TA&FA)
Annualized Return+12%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
OCGN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for OCGN
A.I. Advisor
published General Information

General Information

a company, which engages in the development and commercialization of therapies for eye diseases

Industry Biotechnology

Profile
Details
Industry
N/A
Address
11 Great Valley Parkway
Phone
+1 484 328-4701
Employees
116
Web
https://www.ocugen.com